Kos-Kudła B, Blicharz-Dorniak J, Strzelczyk J et al (2017) Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 68(2):79–110

Article  PubMed  Google Scholar 

Feola T, Puliani G, Sesti F et al (2022) Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study. J Endocrinol Invest 45(4):849–857

Article  CAS  PubMed  Google Scholar 

Puliani G, Di Vito V, Feola T et al (2022) NETest: a systematic review focusing on the prognostic and predictive role. Neuroendocrinology 112(6):523–536

Article  CAS  PubMed  Google Scholar 

Perri G, Prakash LR, Katz MHG (2019) Pancreatic neuroendocrine tumors. Curr Opin Gastroenterol 35(5):468–477

Article  CAS  PubMed  Google Scholar 

Dai M, Mullins CS, Lu L, Alsfasser G, Linnebacher M (2022) Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Surg 14(5):383–396

Article  PubMed  PubMed Central  Google Scholar 

Halfdanarson TR, Rabe KG, Rubin J, Petersen GM (2008) Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol 19(10):1727–1733

Article  CAS  PubMed  PubMed Central  Google Scholar 

Batcher E, Madaj P, Gianoukakis AG (2011) Pancreatic neuroendocrine tumors. Endocr Res 36(1):35–43

Article  PubMed  Google Scholar 

Grozinsky-Glasberg S, Mazeh H, Gross DJ (2015) Clinical features of pancreatic neuroendocrine tumors. J Hepatobiliary Pancreat Sci 22(8):578–585

Article  PubMed  Google Scholar 

Singh S, Dey C, Kennecke H, Kocha W, Maroun J, Metrakos P,et al. Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group. Annals of surgical oncology. 2015;22(8):2685–2699

Article  PubMed  Google Scholar 

Metz DC, Jensen RT (2008) Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 135(5):1469–1492

Article  CAS  PubMed  Google Scholar 

Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours: John Wiley & Sons; 2017.

Pavel M, Öberg K, Falconi M et al (2020) Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(7):844–860

Article  CAS  PubMed  Google Scholar 

Cavalcanti MS, Gönen M, Klimstra DS (2016) The ENETS/WHO grading system for neuroendocrine neoplasms of the gastroenteropancreatic system: a review of the current state, limitations and proposals for modifications. Int J Endocr Oncol 3(3):203–219

Article  PubMed  PubMed Central  Google Scholar 

Wang Z, Jiang W, Zheng L et al (2019) Consideration of age is necessary for increasing the accuracy of the AJCC TNM staging system of pancreatic neuroendocrine tumors. Front Oncol 9:906

Article  PubMed  PubMed Central  Google Scholar 

Fan Y, Li S, Xia X, et al. Oncological outcomes from surgical vs. non-surgical treatments for advanced hypopharyngeal squamous cell carcinoma: a surveillance, epidemiology, and end results-based study. Clin Transl Oncol 2022.

Genpeng L, Yuting S, Xinyi W, et al. Assessment of age as different variable types for determining survival in differentiated thyroid cancer. Endocrine 2022.

Howlader N, Noone AM, Krapcho Me, et al. SEER cancer statistics review, 1975–2016. Bethesda, MD: National Cancer Institute 2019: 1423–37.

Brooks JC, Shavelle RM, Vavra-Musser KN (2019) Life expectancy in pancreatic neuroendocrine cancer. Clin Res Hepatol Gastroenterol 43(1):88–97

Article  PubMed  Google Scholar 

Hu CY, Xing Y, Cormier JN, Chang GJ (2013) Assessing the utility of cancer-registry–processed cause of death in calculating cancer-specific survival. Cancer 119(10):1900–1907

Article  PubMed  Google Scholar 

Harrell Jr FE, Harrell Jr MFE, Hmisc D. Package ‘rms’. Vanderbilt University 2017; 229.

Jalali A, Alvarez-Iglesias A, Roshan D, Newell J (2019) Visualising statistical models using dynamic nomograms. PLoS ONE 14(11):e0225253

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahn B, Jung JK, Jung H, et al. Double Ki-67 and synaptophysin labeling in pancreatic neuroendocrine tumor biopsies. Pancreatology : official journal of the International Association of Pancreatology (IAP) [et al] 2022; 22(3): 427–34.

Wang S-E, Su C-H, Kuo Y-J et al (2011) Comparison of functional and nonfunctional neuroendocrine tumors in the pancreas and peripancreatic region. Pancreas 40(2):253–259

Article  PubMed  Google Scholar 

Muscogiuri G, Altieri B, Albertelli M et al (2020) Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective. Endocrine 69(2):441–450

Article  CAS  PubMed  Google Scholar 

De León-Nava MA, Nava K, Soldevila G et al (2009) Immune sexual dimorphism: effect of gonadal steroids on the expression of cytokines, sex steroid receptors, and lymphocyte proliferation. J Steroid Biochem Mol Biol 113(1–2):57–64

Article  PubMed  Google Scholar 

Wang Y, Wang W, Jin K et al (2017) Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors. Oncol Lett 13(3):1165–1174

Article  CAS  PubMed  PubMed Central  Google Scholar 

Briest F, Wang Y, Arsenic R et al (2018) Immunohistochemical study of mitosis-regulatory proteins in gastroenteropancreatic neuroendocrine neoplasms. Anticancer Res 38(7):3863–3870

Article  CAS  PubMed  Google Scholar 

Chen HY, Zhou YL, Chen YH et al (2020) Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors. World J Gastroenterol 26(25):3638–3649

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang M, Zeng L, Zhang Y et al (2015) TNM staging of pancreatic neuroendocrine tumors: an observational analysis and comparison by both AJCC and ENETS systems from 1 single institution. Medicine 94(12):e660

Article  PubMed  PubMed Central  Google Scholar 

Anderson CW, Bennett JJ (2016) Clinical presentation and diagnosis of pancreatic neuroendocrine tumors. Surg Oncol Clin 25(2):363–374

Article  Google Scholar 

Wang J, Liu J, He C et al (2021) Trends in incidence and survival of patients with pancreatic neuroendocrine neoplasm, 1987–2016. J Oncol 2021:4302675

Article  PubMed  PubMed Central  Google Scholar 

Tomasello G, Ghidini M, Costanzo A et al (2019) Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies. J Gastrointest Oncol 10(2):259–269

Article  PubMed  PubMed Central  Google Scholar 

Scandurra C, Modica R, Maldonato NM et al (2021) Quality of life in patients with neuroendocrine neoplasms: the role of severity, clinical heterogeneity, and resilience. J Clin Endocrinol Metab 106(1):e316–e327

Article  PubMed  Google Scholar 

Modica R, Scandurra C, Maldonato NM et al (2022) Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study. J Endocrinol Invest 45(11):2193–2200

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ai L, Li N, Tan HL et al (2021) Effects of marital status on survival of medullary thyroid cancer stratified by age. Cancer Med 10(24):8829–8837

Article  PubMed  PubMed Central  Google Scholar 

Hain E, Sindayigaya R, Fawaz J et al (2019) Surgical management of pancreatic neuroendocrine tumors: an introduction. Expert Rev Anticancer Ther 19(12):1089–1100

Article  CAS  PubMed  Google Scholar